UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bulk electricity storage technologies for load-leveling operation – An economic assessment for the Austrian and German power market

International journal of electrical power & energy systems, 2014-07, Vol.59, p.111-122

2014

Volltextzugriff (PDF)

Incidence and risk factors of central nervous system recurrence in aggressive lymphoma—a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)

Annals of oncology, 2007-01, Vol.18 (1), p.149-157

2007

Volltextzugriff (PDF)

Electric storage in California’s commercial buildings

Applied energy, 2013-04, Vol.104, p.711-722

2013

Volltextzugriff (PDF)

Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin’s lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL)

Annals of oncology, 2003-06, Vol.14 (6), p.881-893

2003

Volltextzugriff (PDF)

Optimal Planning and Operation of Smart Grids with Electric Vehicle Interconnection

Journal of energy engineering, 2012-06, Vol.138 (2), p.95-108

2012

Volltextzugriff (PDF)

Szenarien der Elektrifizierung des Antriebsstrangs individueller PKW bis 2050 in Österreich

Elektrotechnik und Informationstechnik, 2008-11, Vol.125 (11), p.367-371

2008

Volltextzugriff (PDF)

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL

Blood, 2004-08, Vol.104 (3), p.634-641

2004

Volltextzugriff (PDF)

Intraoperative mitomycin in primary pterygium excision: A prospective, randomized trial

Ophthalmology (Rochester, Minn.), 1997-05, Vol.104 (5), p.844-848

1997

Volltextzugriff (PDF)

Bacterial and Fungal Endophthalmitis After Penetrating Keratoplasty

American journal of ophthalmology, 1993-03, Vol.115 (3), p.309-316

1993

Volltextzugriff (PDF)

The interleukin-10 gene promoter polymorphism −1087AG does not correlate with clinical outcome in non-Hodgkin's lymphoma

Genes and immunity, 2007-03, Vol.8 (2), p.164-167

2007

Volltextzugriff (PDF)

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL

Blood, 2004-08, Vol.104 (3), p.626-633

2004

Volltextzugriff (PDF)

NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity

Circulation (New York, N.Y.), 2005-12, Vol.112 (24), p.3754-3762

2005

Volltextzugriff (PDF)

Comparison of portable automated keratometry and manual keratometry for IOL calculation

Journal of cataract and refractive surgery, 1997-10, Vol.23 (8), p.1213-1216

1997

Volltextzugriff (PDF)

Magnetkrampftherapie bei schwerer Depression

Nervenheilkunde, 2015, Vol.34 (12), p.1012-1015

2015

Volltextzugriff (PDF)

Dose-escalated CHOP plus etoposide (MegaCHOEP) followed by repeated stem cell transplantation for primary treatment of aggressive high-risk non-Hodgkin lymphoma

Blood, 2006-04, Vol.107 (8), p.3058-3064

2006

Volltextzugriff (PDF)

Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (MegaCHOEP) and autologous stem cell transplantation : Early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma

Cancer, 2006, Vol.106 (1), p.136-145

2006

Volltextzugriff (PDF)

Long-term safety follow-up of an anterior chamber angle-supported phakic intraocular lens

Journal of cataract and refractive surgery, 2017-09, Vol.43 (9), p.1163-1170

2017

Volltextzugriff (PDF)

Electric storage technologies for the future power system - An economic assessment

2012 9th International Conference on the European Energy Market, 2012, p.1-8

Kloess, M.

2012

Volltextzugriff (PDF)

Bi-weekly dosing preserves the efficacy of rituximab in elderly patients with poor-prognosis DLBCL: Results from the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study group (DSHNHL)

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.7536-7536

2006

Volltextzugriff (PDF)

CHOP/CHOEP-14 followed by consolidation with alemtuzumab in untreated aggressive T-cell lymphomas (DSHNHL 2003–1): Feasibility and toxicity of a phase II trial of the German High Grade Non-Hodgkin’s Lymphoma Group DSHNHL

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.7538-7538

2006

Volltextzugriff (PDF)

Dose escalated CHOP + etoposide and repetitive autologous stem cell transplantation (MegaCHOEP) with and without rituximab for primary treatment of aggressive NHL

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.6654-6654

2005

Volltextzugriff (PDF)

Intraoperative Mitomycin in Primary Pterygium Excision

Ophthalmology (Rochester, Minn.), 1997-05, Vol.104 (5), p.844-848

1997

Volltextzugriff (PDF)

Mitomycin C after Pterygium Excision

Ophthalmology (Rochester, Minn.), 1993-03, Vol.100 (3), p.292-293

1993

Volltextzugriff (PDF)

Jugendliche und junge Erwachsene in der ambulanten Suchthilfe. Empirische Befunde vor dem Hintergrund des Kinder- und Jugendhilfegesetzes

Suchttherapie, 2005, Vol.6 (1), p.20-27

2005

Volltextzugriff (PDF)

Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin’s lymphoma: results from the NHL-B trial of the GermanHigh-Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL)

Annals of oncology, 2003-06, Vol.14 (6), p.881-893

2003

Volltextzugriff (PDF)

1 – 25 von 133

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Englisch
(70)
Deutsch
(63)

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Humans
(37)
Life Sciences & Biomedicine
(37)
Female
(19)
Male
(18)
Biological And Medical Sciences
(16)
Medical Sciences
(14)
Adult
(13)
Middle Aged
(13)
Technology
(13)
Animals
(12)
Aged
(10)
Pharmacology. Drug Treatments
(8)
Physical Sciences
(8)
Physics
(8)
Adolescent
(7)
Antineoplastic Agents
(7)
Physics, Applied
(7)
Antineoplastic Combined Chemotherapy Protocols - Administration & Dosage
(6)
Cyclophosphamide - Administration & Dosage
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bulk electricity storage technologies for load-leveling operation – An economic assessment for the Austrian and German power market

Incidence and risk factors of central nervous system recurrence in aggressive lymphoma—a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)

Electric storage in California’s commercial buildings

Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin’s lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL)

Optimal Planning and Operation of Smart Grids with Electric Vehicle Interconnection

Szenarien der Elektrifizierung des Antriebsstrangs individueller PKW bis 2050 in Österreich

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL

Intraoperative mitomycin in primary pterygium excision: A prospective, randomized trial

Bacterial and Fungal Endophthalmitis After Penetrating Keratoplasty

The interleukin-10 gene promoter polymorphism −1087AG does not correlate with clinical outcome in non-Hodgkin's lymphoma

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL

NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity

Comparison of portable automated keratometry and manual keratometry for IOL calculation

Magnetkrampftherapie bei schwerer Depression

Dose-escalated CHOP plus etoposide (MegaCHOEP) followed by repeated stem cell transplantation for primary treatment of aggressive high-risk non-Hodgkin lymphoma

Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (MegaCHOEP) and autologous stem cell transplantation : Early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma

Long-term safety follow-up of an anterior chamber angle-supported phakic intraocular lens

Electric storage technologies for the future power system - An economic assessment

Bi-weekly dosing preserves the efficacy of rituximab in elderly patients with poor-prognosis DLBCL: Results from the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study group (DSHNHL)

CHOP/CHOEP-14 followed by consolidation with alemtuzumab in untreated aggressive T-cell lymphomas (DSHNHL 2003–1): Feasibility and toxicity of a phase II trial of the German High Grade Non-Hodgkin’s Lymphoma Group DSHNHL

Dose escalated CHOP + etoposide and repetitive autologous stem cell transplantation (MegaCHOEP) with and without rituximab for primary treatment of aggressive NHL

Intraoperative Mitomycin in Primary Pterygium Excision

Mitomycin C after Pterygium Excision

Jugendliche und junge Erwachsene in der ambulanten Suchthilfe. Empirische Befunde vor dem Hintergrund des Kinder- und Jugendhilfegesetzes

Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin’s lymphoma: results from the NHL-B trial of the GermanHigh-Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL)

Suchergebnisse filtern